Browsing publications by Dr Jonathan Wallis

Newcastle AuthorsTitleYearFull text
Dr Ashleigh Herriott
Dr Susan Tudhope
Gesa Junge
Natalie Rodrigues
Dr Miranda Patterson
et al.
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in Chronic Lymphocytic Leukaemia2015
Dr Stephen Wright
Dr Christopher Snowden
Dr Jonathan Wallis
Cardiopulmonary exercise testing before and after blood transfusion: a prospective clinical study2014
Dr Samuel Moses
Professor Stephen O'Brien
Dr Tobias Menne
Dr Jonathan Wallis
Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia2014
Dr Jonathan Wallis
Ofatumumab plus chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukaemia (CLL): results of the phase III study COMPLEMENT 1 (OMB110911; NCRN-adopted)2014
Dr Jonathan Wallis
Ten-year pattern of red blood cell use in the North of England2013
Dr Jonathan Wallis
Dr R Neely
An unusual case of secondary hyperlipidaemia2012
Dr Samuel Moses
Professor Stephen O'Brien
Dr Tobias Menne
Dr Jonathan Wallis
Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia2012
Dr Elaine Willmore
Natalie Rodrigues
Dr Jonathan Wallis
Professor Nicola Curtin
High Activity of Poly(ADP-Ribose) Polymerase in Chronic Lymphocytic Leukemia2012
Dr Venetia Bigley
Dr Muz Haniffa
Dr Xiao Wang
Dr Rachel Dickinson
Dr Naomi McGovern
et al.
Dendritic cell, monocyte, B and NK lymphoid deficiency: a novel but potentially fatal haematological disorder curable with haematopoietic stem cell transplantation2011
Dr Jonathan Wallis
Disentangling anemia and transfusion2011
12345